18216-53-0

Pyrazino[2,3-b]quinoxaline, 2,3-dimethyl-

3-Pyrrolidinol,1-[[2-(2,4-dichlorophenyl)-6-fluoro-2-(4-fluorophenyl)-1,3-benzodioxol-5-yl]carbonyl]-, (3S)-

3-Pyrrolidinol, 1-cyclopropyl-, methanesulfonate (ester)

3-Pyrrolidinol, 1-(2-fluorophenyl)-

3-Pyrrolidinecarboxamide,N-[4-[(4,6-dimethyl-2-pyrimidinyl)amino]phenyl]-1-(3-methoxyphenyl)-5-oxo-

Benzenemethanamine,N-[1-cyclohexyl-3-(trimethylsilyl)-2-propynyl]-N-(phenylmethyl)-

4-Isothiazolecarboxylic acid, 5-bromo-3-phenyl-

3-Pyrrolidinol, 1-[2-(2-methyl-1H-indol-3-yl)ethyl]-, monohydrochloride

Benzenemethanamine, N-[(1S)-1-ethynylpentyl]-N-(phenylmethyl)-

1-(1,3-dioxolan-2-ylmethyl)-1,4-dihydro-4-oxo-3-(phenylmethoxy)-2,5-pyridinedicarboxylic acid 5-ethyl 2-methyl ester

1H-Pyrrolo[2,3-b]pyridin-3-amine, 2-ethyl-

2,7-Diazaspiro[4.5]decane-7-carboxylic acid, 2-methyl-1-oxo-, 1,1-dimethylethyl ester

3-Pyrrolidinol, 1-[2-[(4-iodo-2-methylphenyl)amino]-5-nitrobenzoyl]-

3-Pyrrolidinecarboxamide,N-[4-(dimethylamino)phenyl]-1-(2-naphthalenyl)-5-oxo-

3-Pyrrolidinol, 1-[2-(6-chloro-1H-indazol-3-yl)-1H-benzimidazol-5-yl]-,(3R)-

3-Cyano-6-fluoro-4-azaindole

Imidazo[1,2-a]pyrimidin-5(1H)-one,1,7-dimethyl-6-[2-[4-[[1-[(2-methyl-5-oxazolyl)methyl]-1H-benzimidazol-2-yl]amino]-1-piperidinyl]ethyl]-

Carbamic acid, hydroxy-, (5-nitro-1H-indazol-1-yl)methyl ester

4-Isobenzofuranol,1,3,4,5,6,7-hexahydro-7,7-dimethyl-3-(2-methyl-1-propenyl)-, benzoate,(3R,4S)-rel-

4-Isothiazolecarboxylic acid, 5-(acetylamino)-3-methyl-, ethyl ester

3-Pyrrolidinol, 1-[(4-butoxyphenyl)sulfonyl]-

Methanone,[5-(hydroxyphenylmethylene)-3-(1-methylcyclohexyl)-1,3-cyclopentadien-1-yl]phenyl-, (Z)-

3-Pyrrolidinecarboxylic acid, 1-(2,5-dimethoxyphenyl)-5-oxo-

4-Isoquinolinecarbonitrile, 5,6,7,8-tetrahydro-3-methyl-

N-(1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)-2-(3-chloro-2-methoxyphenylamino)acetamide

3-Pyrrolidinecarboxamide,N-[5-bromo-6-(2-thienyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-1-(phenylmethyl)-

1H-Benzimidazol-2-amine,1-[(2-methyl-5-oxazolyl)methyl]-N-[1-[(3,4,5-trimethoxyphenyl)methyl]-4-piperidinyl]-

Benzenamine, N,N-dimethyl-3-[2-(1-pentyl-4-piperidinyl)ethoxy]-,ethanedioate (1:2)

Piperidine, 1-[[(4-fluorophenyl)dimethylsilyl]methyl]-, (E)-2-butenedioate

1-(Phenylsulfonyl)-6-hydroxy-2-iodo-4-azaindole

3-Pyrrolidinol, 1-[[4-(2-benzothiazolyloxy)phenyl]methyl]-, (3R)-

1,2,4-Triazin-5(4H)-one,6-(1,1-dimethylethyl)-4-[(diphenylmethylene)amino]-3-(methylthio)-

3-Pyrrolidinecarboxamide,N-[4-[(4,6-dimethyl-2-pyrimidinyl)ethylamino]phenyl]-5-oxo-1-[2-(2-thienyl)ethyl]-

3-Pyrrolidinol, 1-[2-[(5,6-diphenylfuro[2,3-d]pyrimidin-4-yl)amino]ethyl]-

4-Isoxazolecarboxamide,5-amino-3-(3-thienyl)-N-[4-(trifluoromethoxy)phenyl]-

3-Pyrrolidinol, 1-[2-(5-pyrimidinyl)ethyl]-, methanesulfonate (ester), (3S)-

3-Quinolinecarbonitrile,4-(1,3-benzodioxol-4-ylamino)-6-methoxy-7-[3-(methyl-2-propynylamino)propoxy]-

18216-53-0 msds

CAS No 18216-53-0 supplier

CASNo 18216-53-0 distributor

CAS # 18216-53-0 manufacturer

CAS Number 18216-53-0 safety

CAS RN 18216-53-0 wholesale

2026-10-14 Pyrazino[2,3-b]quinoxaline, 2,3-dimethyl-,CAS No.18216-53-0,Formula:C12H10N4. Find Related Products for Bulk Production or Scientific Research